Vivos Inc (RDGL)

[SC8]

Read quarterly reports. Estimates for all expenses including initial human trials are all there and, of course, will be going up above those figures cuz of rapid inflation, especially in health care. Sorry, but funds raised last Thursday are a small fraction of what's needed. Besides, who in their right mind would be sell huge piece of company at $0.07/share when you could fund human trails at far less dilution post IDE? Gotta go with Occam on this one and conclude funds are to best assure sufficient cash to progress IDE application. Likely at least a quarter's worth of cash or more will still be there post IDE submission, but rest assured should RDGL receive IDE approval, there will be some minor dilution at that time to fund trials. Biggest and lengthiest bottleneck will be patient recruitment, and the Mayo Docs will be paid for everything they do for RDGL from the get-go.